XML 40 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Derivative Financial Instruments
12 Months Ended
Dec. 29, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
 
Our derivative financial instruments reduce our exposure to fluctuations in foreign exchange rates. We predominantly designate our derivative financial instruments as cash flow hedges.
 
Counterparties expose us to credit loss in the event of non-performance on hedges.  We monitor our exposure to counterparty non-performance risk both at inception of the hedge and at least quarterly thereafter.  However, because the contracts are entered into with highly rated financial institutions, we do not anticipate non-performance by any of these counterparties.  The exposure is usually the amount of the unrealized gains, if any, in such contracts.

Because of the high degree of effectiveness between the hedging instrument and the underlying exposure being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the cash flows or fair value of the underlying exposures being hedged.  In addition, we perform an assessment of hedge effectiveness, both at inception and at least quarterly thereafter, to determine whether the financial instruments that are used in hedging transactions are effective at offsetting changes in the cash flows or fair value of the related underlying exposures. A cash flow hedge requires that the change in the fair value of a derivative instrument be recognized in other comprehensive income, a component of shareholders’ equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item.
 
Certain of our derivative instruments contain provisions that require the current credit relationship between us and our counterparty to be maintained throughout the term of the derivative instruments.  If that credit relationship changes, certain provisions could be triggered, and the counterparty could request immediate collateralization of derivative instruments in net liability position above a certain threshold.  There are no derivative instruments with a credit-risk-related contingent feature that are in a liability position on December 29, 2017. As of December 29, 2017, no triggering event has occurred and thus we are not required to post collateral.  If the credit-risk-related contingent features underlying these agreements were triggered on December 29, 2017, we would not be required to post collateral to its counterparty because the collateralization threshold has not been met.

Foreign Currency Hedges
 
We are exposed to fluctuations in currency exchange rates against the U.S. dollar on our results of operations and financial condition and we mitigate that exposure by entering into foreign currency forward contracts. Certain of our subsidiaries periodically enter into foreign currency forward contracts in order to hedge portions of forecasted sales or cost of sales denominated in foreign currencies with forward contracts and options, which generally expire within one year. At December 29, 2017, our foreign currency forward contracts will hedge a portion of our 2018 foreign currency exposure.
 
We designate our foreign currency forward contracts as single-purpose cash flow hedges of forecasted cash flows.  



18.  Derivative Financial Instruments (continued)

We had the following outstanding foreign currency forward contracts as of December 29, 2017:
 
Foreign Currency Contracts Qualifying as Cash Flow Hedges:
 
Notional Amount
Euro
85.0

 
million
Korean won
KRW
31,735.0

 
million
 

The following table reflects the fair values of derivative instruments as of December 29, 2017 (U.S. dollars in millions):

 
Derivatives Designated as Hedging Instruments (1)
 
Foreign exchange contracts
 
Balance Sheet Location:
December 29, 2017
 
December 30, 2016
 
Asset derivatives:
 
 
 
 
Prepaid expenses and other current assets
$

 
$
5.4

 
Total asset derivatives
$

 
$
5.4

 
 
 
 
 
 
Liability derivatives:
 

 
 

 
Accounts payable and accrued expenses
$
1.4

 
$

 
Total liability derivatives
$
1.4

 
$

 

(1) See Note 19, "Fair Value Measurements," for fair value disclosures.
(2) We expect that $1.4 million of the fair value of hedges recognized as a net loss in AOCI will be transferred to earnings during the next 12 months along with the effect of the related forecasted transaction.
 
The fair value of our derivatives changed from an asset of $5.4 million as of December 30, 2016 to a liability of $1.4 million as of December 29, 2017, related to our foreign currency cash flow hedges.  For foreign currency hedges, these fluctuations are primarily driven by the strengthening or weakening of the U.S. dollar compared to currencies being hedged relative to the contracted exchange rates and the settling of a number of contracts throughout 2017. During 2017, certain derivative contracts to hedge the euro and Japanese yen relative to our sales were settled; certain derivative contracts to hedge the Korean won relative to our cost of sales were also settled. The change in 2017 was primarily related to the settling of the majority of the contracts throughout 2017.

The following table reflects the effect of derivative instruments on the Consolidated Statements of Income for the years ended December 29, 2017 and December 30, 2016 (U.S. dollars in millions):

 
Derivatives in Cash Flow
Hedging Relationships
Amount of (Loss) Gain Recognized in Other
Comprehensive Income on Derivatives
(Effective Portion)
 
Location of (Loss) Gain Reclassified
from AOCI into
Income (Effective
Portion)
 
Amount of (Loss) Gain Reclassified from
AOCI into Income (Effective Portion)
 
Year ended
 
 
 
Year ended
 
December 29, 2017
 
December 30, 2016
 
 
 
December 29, 2017
 
December 30, 2016
Foreign exchange contracts
$
(5.4
)
 
$
(7.2
)
 
Net sales
 
$
(1.2
)
 
$
7.5

Foreign exchange contracts
(1.4
)
 
0.7

 
Cost of products sold
 
0.3

 
0.5

Total
$
(6.8
)
 
$
(6.5
)
 
 
 
$
(0.9
)
 
$
8.0